Skip to main
ELMD
ELMD logo

Electromed (ELMD) Stock Forecast & Price Target

Electromed (ELMD) Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Electromed Inc demonstrated notable growth in the homecare segment, with revenue increasing by 14.8% to $14.1 million, driven by enhanced sales rep productivity and effective demand generation strategies. Additionally, the company reported significant growth in distributor and hospital sales, with increases of 41% and 52%, respectively, indicating strong market demand for its airway clearance products. Although SG&A expenses rose by 17.2% due to strategic investments in sales and marketing, these expenses are designed to support long-term growth initiatives, painting a favorable outlook for the company's sustained development in both domestic and international markets.

Bears say

Electromed Inc faces significant challenges that contribute to a negative outlook on its stock, including margin compression and increased competition, which could hinder its profitability. Additionally, reduced productivity among sales representatives presents a concern that may impact the overall sales performance and growth drivers for the company's products. Furthermore, any delays in the Pain Management and Wound Care segments becoming significant revenue contributors could further exacerbate the expected decline in growth rates and profit margins.

Electromed (ELMD) has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Electromed and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Electromed (ELMD) Forecast

Analysts have given Electromed (ELMD) a Strong Buy based on their latest research and market trends.

According to 3 analysts, Electromed (ELMD) has a Strong Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $36.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $36.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Electromed (ELMD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.